Ananda Pharma (AQSE:ANA) ROCE % : -49.52% (As of Jul. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Ananda Pharma ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ananda Pharma's annualized ROCE % for the quarter that ended in Jul. 2023 was -49.52%.

Ananda Pharma ROCE % Historical Data

The historical data trend for Ananda Pharma's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ananda Pharma ROCE % Chart

Ananda Pharma Annual Data

Trend

Jan19

Jan20

Jan21

Jan22

Jan23

ROCE %

-48.36

-37.71

-48.18

-113.65

-73.28

Ananda Pharma Semi-Annual Data
	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23
ROCE %	Get a 7-Day Free Trial						-206.76	-81.98	-86.76	-109.06	-49.52

Ananda Pharma ROCE % Calculation

Ananda Pharma's annualized ROCE % for the fiscal year that ended in Jan. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jan. 2023 )		(A: Jan. 2022 )		(A: Jan. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jan. 2023 )		(A: Jan. 2022 )		(A: Jan. 2023 )
	=	-1.053	/	( ( (2.363 - 1.487)	+	(6.509 - 4.511) )	/ 2 )
	=	-1.053	/	( (0.876	+	1.998)	/ 2 )
	=	-1.053	/	1.437
	=	-73.28 %

Ananda Pharma's ROCE % of for the quarter that ended in Jul. 2023 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jul. 2023 )		(Q: Jan. 2023 )		(Q: Jul. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jul. 2023 )		(Q: Jan. 2023 )		(Q: Jul. 2023 )
	=	-1.89	/	( ( (6.509 - 4.511)	+	(7.772 - 2.136) )	/ 2 )
	=	-1.89	/	( ( 1.998	+	5.636 )	/ 2 )
	=	-1.89	/	3.817
	=	-49.52 %

(1) Note: The EBIT data used here is two times the semi-annual (Jul. 2023) EBIT data.

Ananda Pharma (AQSE:ANA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ananda Pharma ROCE % Related Terms

Thank you for viewing the detailed overview of Ananda Pharma's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Ananda Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ananda Pharma PLC (AQSE:ANA) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

60 Gracechurch Street, 6th Floor, London, GBR, EC3V 0HR

Website

http://www.anandadevelopments.com

Ananda Developments PLC provides investment to healthcare market for the companies that develop medicinal or therapeutic cannabis derivatives, or related products including nutraceuticals, dietary supplements, and cosmetic products which contain Cannabis or hemp derived cannabinoids.

Ananda Pharma Headlines

No Headlines